Insiders · Profile

TYNDALL CAPITAL PARTNERS L P

10% owner at Traws Pharma. Filing since 8 Feb 2018. CIK 0001219314

Company
Date
Role
Action
Shares
Amount
Of holding
24 Sep 2019
10% owner
Sold, plan not stated
16,700
$19.87K
2.6%
23 Sep 2019
10% owner
Sold, plan not stated
37,242
$45.97K
5.6%
20 Sep 2019
10% owner
Sold, plan not stated
75,119
$121.43K
10.1%
18 Sep 2019
10% owner
Sold, plan not stated
49,995
$105.01K
6.3%
11 Sep 2019
10% owner
Sold, plan not stated
1,247
$3.43K
0.2%
9 Sep 2019
10% owner
Sold, plan not stated
400
$1.11K
0.1%
6 Sep 2019
10% owner
Sold, plan not stated
5,015
$13.95K
0.6%
5 Sep 2019
10% owner
Sold, plan not stated
400
$1.10K
0.0%
10 Jul 2019
10% owner
Sold, plan not stated
2,742
$7.70K
0.3%
9 Jul 2019
10% owner
Sold, plan not stated
8,185
$23.20K
1.0%
27 Jun 2019
10% owner
Sold, plan not stated
1,458
$5.02K
0.2%
25 Jun 2019
10% owner
Sold, plan not stated
1,380
$4.69K
0.2%
27 Apr 2018
10% owner
Bought
10,147,058
$4.31M
484%
8 Feb 2018
10% owner
Bought
1,100,000
$1.11M
110%
14 decisions on file.